TABLE 1.
Characteristics of study groups in the United States and Denmarka
| Characteristic | CD
|
UC
|
UC
|
Control
|
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical
|
Outpatient
|
Surgical
|
Outpatient
|
Surgical
|
Healthy
|
|||||||
| US | DK | US | DK | US | DK | US | DK | US | DK | US | DK | |
| Total no. | 33 | 50 | 114 | 75 | 35 | 26 | 31 | 75 | 19 | 30 | 198 | 77 |
| Gender; no. (%) of males | 15 (45.5) | 17 (34) | 46 (40.4) | 35 (47) | 19 (54.3) | 16 (62) | 10 (29.4) | 41 (55) | 11 (57.9) | 16 (53) | 84 (42.4) | 40 (52) |
| Age (yr), mean ± SD | 34.2 ± 13.6 | 39.4 ± 14.0 | 40.9 ± 13.4 | 44.8 ± 17.6 | 38.4 ± 12.4 | 42.5 ± 14.7 | 44.2 ± 12.4 | 48.3 ± 16.4 | 43.8 ± 20.1 | 67.8 ± 15.6 | 37.8 ± 13.5 | 42.6 ± 12.1 |
| No. BCG vaccinated (%) | 0 | 37 (78.7) | 0 | 56 (88.9) | 0 | 20 (80.0) | 0 | 67 (88.9) | 0 | 20 (76.9) | 4 (2.0) | 63 (85.1) |
| Disease duration (yr), mean ± SD (range) | 9.5 ± 8.7 (1–37) | 7.8 ± 7.32 (0–26) | 13.3 ± 11.7 (0–40) | 9.1 ± 9.3 (0–41) | 6.5 ± 6.3 (0–23) | 7.0 ± 8.0 (0–25) | 11.5 ± 10.1 (0–36) | 12.4 ± 12.0 (0–53) | NR | 0.2 ± 0.9 (0–4) | NA | NA |
a
Abbreviations: US, United States; DK, Denmark; NR, not reported; NA, not applicable. For percent BCG vaccinated, subjects with unknown vaccination status were excluded from the calculation.